nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—PON1—prostate cancer	0.452	1	CbGaD
Cefazolin—SLC22A11—Conjugated Estrogens—prostate cancer	0.0562	0.163	CbGbCtD
Cefazolin—ABCC4—Conjugated Estrogens—prostate cancer	0.0523	0.152	CbGbCtD
Cefazolin—SLC22A11—Estradiol—prostate cancer	0.0493	0.143	CbGbCtD
Cefazolin—ALB—Abiraterone—prostate cancer	0.041	0.119	CbGbCtD
Cefazolin—SLC22A8—Conjugated Estrogens—prostate cancer	0.0327	0.0949	CbGbCtD
Cefazolin—ALB—Estrone—prostate cancer	0.0296	0.0861	CbGbCtD
Cefazolin—SLC22A8—Estradiol—prostate cancer	0.0287	0.0833	CbGbCtD
Cefazolin—SLC22A6—Conjugated Estrogens—prostate cancer	0.0228	0.0661	CbGbCtD
Cefazolin—ALB—Estradiol—prostate cancer	0.017	0.0494	CbGbCtD
Cefazolin—ALB—Prednisone—prostate cancer	0.0146	0.0425	CbGbCtD
Cefazolin—PON1—bone marrow—prostate cancer	0.00309	0.144	CbGeAlD
Cefazolin—SLC22A8—urine—prostate cancer	0.00303	0.141	CbGeAlD
Cefazolin—TPMT—prostate gland—prostate cancer	0.00182	0.0848	CbGeAlD
Cefazolin—TPMT—seminal vesicle—prostate cancer	0.00154	0.0717	CbGeAlD
Cefazolin—SLC22A11—renal system—prostate cancer	0.00131	0.0611	CbGeAlD
Cefazolin—TPMT—renal system—prostate cancer	0.00124	0.0578	CbGeAlD
Cefazolin—TPMT—urethra—prostate cancer	0.00122	0.0567	CbGeAlD
Cefazolin—ABCC4—prostate gland—prostate cancer	0.0011	0.0509	CbGeAlD
Cefazolin—SLC22A8—prostate gland—prostate cancer	0.00109	0.0505	CbGeAlD
Cefazolin—TPMT—bone marrow—prostate cancer	0.00094	0.0437	CbGeAlD
Cefazolin—TPMT—testis—prostate cancer	0.000803	0.0373	CbGeAlD
Cefazolin—ABCC4—renal system—prostate cancer	0.000747	0.0347	CbGeAlD
Cefazolin—SLC22A8—renal system—prostate cancer	0.000741	0.0344	CbGeAlD
Cefazolin—TPMT—lymph node—prostate cancer	0.000582	0.0271	CbGeAlD
Cefazolin—ABCC4—bone marrow—prostate cancer	0.000565	0.0262	CbGeAlD
Cefazolin—ALB—testis—prostate cancer	0.000499	0.0232	CbGeAlD
Cefazolin—ABCC4—testis—prostate cancer	0.000483	0.0224	CbGeAlD
Cefazolin—ALB—lymph node—prostate cancer	0.000361	0.0168	CbGeAlD
Cefazolin—ABCC4—lymph node—prostate cancer	0.00035	0.0163	CbGeAlD
Cefazolin—Dizziness—Conjugated Estrogens—prostate cancer	8.57e-05	0.000723	CcSEcCtD
Cefazolin—Feeling abnormal—Estradiol—prostate cancer	8.55e-05	0.000721	CcSEcCtD
Cefazolin—Convulsion—Etoposide—prostate cancer	8.54e-05	0.00072	CcSEcCtD
Cefazolin—Dyspepsia—Mitoxantrone—prostate cancer	8.51e-05	0.000718	CcSEcCtD
Cefazolin—Gastrointestinal pain—Estradiol—prostate cancer	8.48e-05	0.000716	CcSEcCtD
Cefazolin—Decreased appetite—Mitoxantrone—prostate cancer	8.4e-05	0.000709	CcSEcCtD
Cefazolin—Abdominal pain upper—Epirubicin—prostate cancer	8.38e-05	0.000707	CcSEcCtD
Cefazolin—Fatigue—Mitoxantrone—prostate cancer	8.33e-05	0.000703	CcSEcCtD
Cefazolin—Vomiting—Goserelin—prostate cancer	8.32e-05	0.000702	CcSEcCtD
Cefazolin—Pain—Mitoxantrone—prostate cancer	8.27e-05	0.000698	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Epirubicin—prostate cancer	8.26e-05	0.000697	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Epirubicin—prostate cancer	8.26e-05	0.000697	CcSEcCtD
Cefazolin—Rash—Goserelin—prostate cancer	8.25e-05	0.000696	CcSEcCtD
Cefazolin—Dermatitis—Goserelin—prostate cancer	8.24e-05	0.000696	CcSEcCtD
Cefazolin—Vomiting—Conjugated Estrogens—prostate cancer	8.24e-05	0.000696	CcSEcCtD
Cefazolin—Urticaria—Estradiol—prostate cancer	8.24e-05	0.000696	CcSEcCtD
Cefazolin—Abdominal pain—Estradiol—prostate cancer	8.2e-05	0.000692	CcSEcCtD
Cefazolin—Body temperature increased—Estradiol—prostate cancer	8.2e-05	0.000692	CcSEcCtD
Cefazolin—Headache—Goserelin—prostate cancer	8.2e-05	0.000692	CcSEcCtD
Cefazolin—Rash—Conjugated Estrogens—prostate cancer	8.17e-05	0.00069	CcSEcCtD
Cefazolin—Dermatitis—Conjugated Estrogens—prostate cancer	8.17e-05	0.000689	CcSEcCtD
Cefazolin—Haemoglobin—Prednisone—prostate cancer	8.15e-05	0.000688	CcSEcCtD
Cefazolin—Headache—Conjugated Estrogens—prostate cancer	8.12e-05	0.000685	CcSEcCtD
Cefazolin—Haemorrhage—Prednisone—prostate cancer	8.11e-05	0.000685	CcSEcCtD
Cefazolin—Confusional state—Etoposide—prostate cancer	8.11e-05	0.000684	CcSEcCtD
Cefazolin—Anaphylactic shock—Etoposide—prostate cancer	8.04e-05	0.000679	CcSEcCtD
Cefazolin—Feeling abnormal—Mitoxantrone—prostate cancer	7.97e-05	0.000672	CcSEcCtD
Cefazolin—Blood creatinine increased—Doxorubicin—prostate cancer	7.95e-05	0.000671	CcSEcCtD
Cefazolin—Gastrointestinal pain—Mitoxantrone—prostate cancer	7.9e-05	0.000667	CcSEcCtD
Cefazolin—Thrombocytopenia—Etoposide—prostate cancer	7.87e-05	0.000664	CcSEcCtD
Cefazolin—Eosinophilia—Epirubicin—prostate cancer	7.85e-05	0.000662	CcSEcCtD
Cefazolin—Flatulence—Capecitabine—prostate cancer	7.81e-05	0.000659	CcSEcCtD
Cefazolin—Nausea—Goserelin—prostate cancer	7.77e-05	0.000656	CcSEcCtD
Cefazolin—Abdominal pain upper—Doxorubicin—prostate cancer	7.75e-05	0.000654	CcSEcCtD
Cefazolin—Nausea—Conjugated Estrogens—prostate cancer	7.7e-05	0.00065	CcSEcCtD
Cefazolin—Urticaria—Mitoxantrone—prostate cancer	7.68e-05	0.000648	CcSEcCtD
Cefazolin—Anorexia—Etoposide—prostate cancer	7.66e-05	0.000647	CcSEcCtD
Cefazolin—Hypersensitivity—Estradiol—prostate cancer	7.64e-05	0.000645	CcSEcCtD
Cefazolin—Body temperature increased—Mitoxantrone—prostate cancer	7.64e-05	0.000645	CcSEcCtD
Cefazolin—Abdominal pain—Mitoxantrone—prostate cancer	7.64e-05	0.000645	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	7.64e-05	0.000645	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	7.64e-05	0.000645	CcSEcCtD
Cefazolin—Anaemia—Docetaxel—prostate cancer	7.57e-05	0.000639	CcSEcCtD
Cefazolin—Pancytopenia—Epirubicin—prostate cancer	7.53e-05	0.000635	CcSEcCtD
Cefazolin—Hypotension—Etoposide—prostate cancer	7.51e-05	0.000634	CcSEcCtD
Cefazolin—Asthenia—Estradiol—prostate cancer	7.44e-05	0.000628	CcSEcCtD
Cefazolin—Neutropenia—Epirubicin—prostate cancer	7.41e-05	0.000625	CcSEcCtD
Cefazolin—Syncope—Docetaxel—prostate cancer	7.34e-05	0.00062	CcSEcCtD
Cefazolin—Pruritus—Estradiol—prostate cancer	7.34e-05	0.000619	CcSEcCtD
Cefazolin—Leukopenia—Docetaxel—prostate cancer	7.33e-05	0.000618	CcSEcCtD
Cefazolin—Anaemia—Capecitabine—prostate cancer	7.33e-05	0.000618	CcSEcCtD
Cefazolin—Eosinophilia—Doxorubicin—prostate cancer	7.26e-05	0.000613	CcSEcCtD
Cefazolin—Loss of consciousness—Docetaxel—prostate cancer	7.2e-05	0.000607	CcSEcCtD
Cefazolin—Somnolence—Etoposide—prostate cancer	7.15e-05	0.000603	CcSEcCtD
Cefazolin—Hypersensitivity—Mitoxantrone—prostate cancer	7.12e-05	0.000601	CcSEcCtD
Cefazolin—Syncope—Capecitabine—prostate cancer	7.11e-05	0.0006	CcSEcCtD
Cefazolin—Diarrhoea—Estradiol—prostate cancer	7.1e-05	0.000599	CcSEcCtD
Cefazolin—Leukopenia—Capecitabine—prostate cancer	7.1e-05	0.000599	CcSEcCtD
Cefazolin—Convulsion—Docetaxel—prostate cancer	7.09e-05	0.000599	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Epirubicin—prostate cancer	7.01e-05	0.000591	CcSEcCtD
Cefazolin—Decreased appetite—Etoposide—prostate cancer	6.99e-05	0.00059	CcSEcCtD
Cefazolin—Loss of consciousness—Capecitabine—prostate cancer	6.97e-05	0.000588	CcSEcCtD
Cefazolin—Pancytopenia—Doxorubicin—prostate cancer	6.96e-05	0.000588	CcSEcCtD
Cefazolin—Renal failure—Epirubicin—prostate cancer	6.95e-05	0.000586	CcSEcCtD
Cefazolin—Asthenia—Mitoxantrone—prostate cancer	6.94e-05	0.000585	CcSEcCtD
Cefazolin—Fatigue—Etoposide—prostate cancer	6.93e-05	0.000585	CcSEcCtD
Cefazolin—Stomatitis—Epirubicin—prostate cancer	6.89e-05	0.000581	CcSEcCtD
Cefazolin—Pain—Etoposide—prostate cancer	6.88e-05	0.00058	CcSEcCtD
Cefazolin—Dizziness—Estradiol—prostate cancer	6.86e-05	0.000579	CcSEcCtD
Cefazolin—Neutropenia—Doxorubicin—prostate cancer	6.86e-05	0.000579	CcSEcCtD
Cefazolin—Confusional state—Docetaxel—prostate cancer	6.74e-05	0.000569	CcSEcCtD
Cefazolin—Anaphylactic shock—Docetaxel—prostate cancer	6.68e-05	0.000564	CcSEcCtD
Cefazolin—Feeling abnormal—Etoposide—prostate cancer	6.63e-05	0.000559	CcSEcCtD
Cefazolin—Diarrhoea—Mitoxantrone—prostate cancer	6.61e-05	0.000558	CcSEcCtD
Cefazolin—Vomiting—Estradiol—prostate cancer	6.6e-05	0.000557	CcSEcCtD
Cefazolin—Agranulocytosis—Epirubicin—prostate cancer	6.6e-05	0.000557	CcSEcCtD
Cefazolin—Gastrointestinal pain—Etoposide—prostate cancer	6.58e-05	0.000555	CcSEcCtD
Cefazolin—Shock—Docetaxel—prostate cancer	6.57e-05	0.000555	CcSEcCtD
Cefazolin—Thrombocytopenia—Docetaxel—prostate cancer	6.54e-05	0.000552	CcSEcCtD
Cefazolin—Rash—Estradiol—prostate cancer	6.54e-05	0.000552	CcSEcCtD
Cefazolin—Dermatitis—Estradiol—prostate cancer	6.54e-05	0.000552	CcSEcCtD
Cefazolin—Anaemia—Prednisone—prostate cancer	6.53e-05	0.000551	CcSEcCtD
Cefazolin—Confusional state—Capecitabine—prostate cancer	6.52e-05	0.000551	CcSEcCtD
Cefazolin—Headache—Estradiol—prostate cancer	6.5e-05	0.000548	CcSEcCtD
Cefazolin—Agitation—Prednisone—prostate cancer	6.49e-05	0.000548	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	6.48e-05	0.000547	CcSEcCtD
Cefazolin—Renal failure—Doxorubicin—prostate cancer	6.43e-05	0.000542	CcSEcCtD
Cefazolin—Urticaria—Etoposide—prostate cancer	6.39e-05	0.000539	CcSEcCtD
Cefazolin—Haemoglobin—Epirubicin—prostate cancer	6.38e-05	0.000538	CcSEcCtD
Cefazolin—Stomatitis—Doxorubicin—prostate cancer	6.37e-05	0.000538	CcSEcCtD
Cefazolin—Anorexia—Docetaxel—prostate cancer	6.37e-05	0.000538	CcSEcCtD
Cefazolin—Shock—Capecitabine—prostate cancer	6.37e-05	0.000537	CcSEcCtD
Cefazolin—Abdominal pain—Etoposide—prostate cancer	6.36e-05	0.000536	CcSEcCtD
Cefazolin—Body temperature increased—Etoposide—prostate cancer	6.36e-05	0.000536	CcSEcCtD
Cefazolin—Haemorrhage—Epirubicin—prostate cancer	6.34e-05	0.000535	CcSEcCtD
Cefazolin—Hepatitis—Epirubicin—prostate cancer	6.34e-05	0.000535	CcSEcCtD
Cefazolin—Thrombocytopenia—Capecitabine—prostate cancer	6.33e-05	0.000535	CcSEcCtD
Cefazolin—Syncope—Prednisone—prostate cancer	6.33e-05	0.000534	CcSEcCtD
Cefazolin—Hypotension—Docetaxel—prostate cancer	6.24e-05	0.000527	CcSEcCtD
Cefazolin—Loss of consciousness—Prednisone—prostate cancer	6.21e-05	0.000524	CcSEcCtD
Cefazolin—Anorexia—Capecitabine—prostate cancer	6.17e-05	0.00052	CcSEcCtD
Cefazolin—Nausea—Estradiol—prostate cancer	6.16e-05	0.00052	CcSEcCtD
Cefazolin—Vomiting—Mitoxantrone—prostate cancer	6.15e-05	0.000519	CcSEcCtD
Cefazolin—Convulsion—Prednisone—prostate cancer	6.12e-05	0.000516	CcSEcCtD
Cefazolin—Agranulocytosis—Doxorubicin—prostate cancer	6.1e-05	0.000515	CcSEcCtD
Cefazolin—Rash—Mitoxantrone—prostate cancer	6.1e-05	0.000514	CcSEcCtD
Cefazolin—Dermatitis—Mitoxantrone—prostate cancer	6.09e-05	0.000514	CcSEcCtD
Cefazolin—Headache—Mitoxantrone—prostate cancer	6.06e-05	0.000511	CcSEcCtD
Cefazolin—Hypotension—Capecitabine—prostate cancer	6.05e-05	0.00051	CcSEcCtD
Cefazolin—Erythema multiforme—Epirubicin—prostate cancer	6e-05	0.000506	CcSEcCtD
Cefazolin—Somnolence—Docetaxel—prostate cancer	5.94e-05	0.000501	CcSEcCtD
Cefazolin—Hypersensitivity—Etoposide—prostate cancer	5.92e-05	0.0005	CcSEcCtD
Cefazolin—Haemoglobin—Doxorubicin—prostate cancer	5.9e-05	0.000498	CcSEcCtD
Cefazolin—Dyspepsia—Docetaxel—prostate cancer	5.88e-05	0.000496	CcSEcCtD
Cefazolin—Hepatitis—Doxorubicin—prostate cancer	5.87e-05	0.000495	CcSEcCtD
Cefazolin—Haemorrhage—Doxorubicin—prostate cancer	5.87e-05	0.000495	CcSEcCtD
Cefazolin—Decreased appetite—Docetaxel—prostate cancer	5.81e-05	0.00049	CcSEcCtD
Cefazolin—Asthenia—Etoposide—prostate cancer	5.77e-05	0.000487	CcSEcCtD
Cefazolin—Anaphylactic shock—Prednisone—prostate cancer	5.76e-05	0.000486	CcSEcCtD
Cefazolin—Fatigue—Docetaxel—prostate cancer	5.76e-05	0.000486	CcSEcCtD
Cefazolin—Nausea—Mitoxantrone—prostate cancer	5.74e-05	0.000485	CcSEcCtD
Cefazolin—Pain—Docetaxel—prostate cancer	5.71e-05	0.000482	CcSEcCtD
Cefazolin—Dyspepsia—Capecitabine—prostate cancer	5.7e-05	0.000481	CcSEcCtD
Cefazolin—Pruritus—Etoposide—prostate cancer	5.69e-05	0.00048	CcSEcCtD
Cefazolin—Shock—Prednisone—prostate cancer	5.67e-05	0.000478	CcSEcCtD
Cefazolin—Decreased appetite—Capecitabine—prostate cancer	5.62e-05	0.000475	CcSEcCtD
Cefazolin—Fatigue—Capecitabine—prostate cancer	5.58e-05	0.000471	CcSEcCtD
Cefazolin—Erythema multiforme—Doxorubicin—prostate cancer	5.55e-05	0.000468	CcSEcCtD
Cefazolin—Pain—Capecitabine—prostate cancer	5.53e-05	0.000467	CcSEcCtD
Cefazolin—Feeling abnormal—Docetaxel—prostate cancer	5.51e-05	0.000465	CcSEcCtD
Cefazolin—Diarrhoea—Etoposide—prostate cancer	5.5e-05	0.000464	CcSEcCtD
Cefazolin—Anorexia—Prednisone—prostate cancer	5.49e-05	0.000464	CcSEcCtD
Cefazolin—Gastrointestinal pain—Docetaxel—prostate cancer	5.46e-05	0.000461	CcSEcCtD
Cefazolin—Flatulence—Epirubicin—prostate cancer	5.44e-05	0.000459	CcSEcCtD
Cefazolin—Feeling abnormal—Capecitabine—prostate cancer	5.33e-05	0.00045	CcSEcCtD
Cefazolin—Dizziness—Etoposide—prostate cancer	5.32e-05	0.000449	CcSEcCtD
Cefazolin—Gastrointestinal pain—Capecitabine—prostate cancer	5.29e-05	0.000446	CcSEcCtD
Cefazolin—Abdominal pain—Docetaxel—prostate cancer	5.28e-05	0.000446	CcSEcCtD
Cefazolin—Body temperature increased—Docetaxel—prostate cancer	5.28e-05	0.000446	CcSEcCtD
Cefazolin—Urticaria—Capecitabine—prostate cancer	5.14e-05	0.000434	CcSEcCtD
Cefazolin—Abdominal pain—Capecitabine—prostate cancer	5.11e-05	0.000432	CcSEcCtD
Cefazolin—Body temperature increased—Capecitabine—prostate cancer	5.11e-05	0.000432	CcSEcCtD
Cefazolin—Vomiting—Etoposide—prostate cancer	5.11e-05	0.000431	CcSEcCtD
Cefazolin—Anaemia—Epirubicin—prostate cancer	5.1e-05	0.000431	CcSEcCtD
Cefazolin—Agitation—Epirubicin—prostate cancer	5.08e-05	0.000428	CcSEcCtD
Cefazolin—Dyspepsia—Prednisone—prostate cancer	5.07e-05	0.000428	CcSEcCtD
Cefazolin—Rash—Etoposide—prostate cancer	5.07e-05	0.000428	CcSEcCtD
Cefazolin—Dermatitis—Etoposide—prostate cancer	5.07e-05	0.000427	CcSEcCtD
Cefazolin—Headache—Etoposide—prostate cancer	5.04e-05	0.000425	CcSEcCtD
Cefazolin—Flatulence—Doxorubicin—prostate cancer	5.04e-05	0.000425	CcSEcCtD
Cefazolin—Decreased appetite—Prednisone—prostate cancer	5.01e-05	0.000423	CcSEcCtD
Cefazolin—Fatigue—Prednisone—prostate cancer	4.97e-05	0.000419	CcSEcCtD
Cefazolin—Syncope—Epirubicin—prostate cancer	4.95e-05	0.000418	CcSEcCtD
Cefazolin—Leukopenia—Epirubicin—prostate cancer	4.94e-05	0.000417	CcSEcCtD
Cefazolin—Hypersensitivity—Docetaxel—prostate cancer	4.92e-05	0.000415	CcSEcCtD
Cefazolin—Loss of consciousness—Epirubicin—prostate cancer	4.85e-05	0.00041	CcSEcCtD
Cefazolin—Asthenia—Docetaxel—prostate cancer	4.79e-05	0.000405	CcSEcCtD
Cefazolin—Convulsion—Epirubicin—prostate cancer	4.79e-05	0.000404	CcSEcCtD
Cefazolin—Nausea—Etoposide—prostate cancer	4.78e-05	0.000403	CcSEcCtD
Cefazolin—Hypersensitivity—Capecitabine—prostate cancer	4.77e-05	0.000402	CcSEcCtD
Cefazolin—Feeling abnormal—Prednisone—prostate cancer	4.75e-05	0.000401	CcSEcCtD
Cefazolin—Pruritus—Docetaxel—prostate cancer	4.73e-05	0.000399	CcSEcCtD
Cefazolin—Anaemia—Doxorubicin—prostate cancer	4.72e-05	0.000399	CcSEcCtD
Cefazolin—Gastrointestinal pain—Prednisone—prostate cancer	4.71e-05	0.000398	CcSEcCtD
Cefazolin—Agitation—Doxorubicin—prostate cancer	4.7e-05	0.000396	CcSEcCtD
Cefazolin—Asthenia—Capecitabine—prostate cancer	4.64e-05	0.000392	CcSEcCtD
Cefazolin—Syncope—Doxorubicin—prostate cancer	4.58e-05	0.000387	CcSEcCtD
Cefazolin—Urticaria—Prednisone—prostate cancer	4.58e-05	0.000386	CcSEcCtD
Cefazolin—Pruritus—Capecitabine—prostate cancer	4.58e-05	0.000386	CcSEcCtD
Cefazolin—Leukopenia—Doxorubicin—prostate cancer	4.57e-05	0.000386	CcSEcCtD
Cefazolin—Diarrhoea—Docetaxel—prostate cancer	4.57e-05	0.000386	CcSEcCtD
Cefazolin—Abdominal pain—Prednisone—prostate cancer	4.56e-05	0.000384	CcSEcCtD
Cefazolin—Body temperature increased—Prednisone—prostate cancer	4.56e-05	0.000384	CcSEcCtD
Cefazolin—Confusional state—Epirubicin—prostate cancer	4.54e-05	0.000384	CcSEcCtD
Cefazolin—Anaphylactic shock—Epirubicin—prostate cancer	4.51e-05	0.00038	CcSEcCtD
Cefazolin—Loss of consciousness—Doxorubicin—prostate cancer	4.49e-05	0.000379	CcSEcCtD
Cefazolin—Shock—Epirubicin—prostate cancer	4.43e-05	0.000374	CcSEcCtD
Cefazolin—Convulsion—Doxorubicin—prostate cancer	4.43e-05	0.000374	CcSEcCtD
Cefazolin—Diarrhoea—Capecitabine—prostate cancer	4.43e-05	0.000374	CcSEcCtD
Cefazolin—Dizziness—Docetaxel—prostate cancer	4.42e-05	0.000373	CcSEcCtD
Cefazolin—Thrombocytopenia—Epirubicin—prostate cancer	4.41e-05	0.000372	CcSEcCtD
Cefazolin—Anorexia—Epirubicin—prostate cancer	4.3e-05	0.000363	CcSEcCtD
Cefazolin—Dizziness—Capecitabine—prostate cancer	4.28e-05	0.000361	CcSEcCtD
Cefazolin—Vomiting—Docetaxel—prostate cancer	4.25e-05	0.000359	CcSEcCtD
Cefazolin—Hypersensitivity—Prednisone—prostate cancer	4.25e-05	0.000358	CcSEcCtD
Cefazolin—Rash—Docetaxel—prostate cancer	4.21e-05	0.000356	CcSEcCtD
Cefazolin—Hypotension—Epirubicin—prostate cancer	4.21e-05	0.000355	CcSEcCtD
Cefazolin—Dermatitis—Docetaxel—prostate cancer	4.21e-05	0.000355	CcSEcCtD
Cefazolin—Confusional state—Doxorubicin—prostate cancer	4.21e-05	0.000355	CcSEcCtD
Cefazolin—Headache—Docetaxel—prostate cancer	4.19e-05	0.000353	CcSEcCtD
Cefazolin—Anaphylactic shock—Doxorubicin—prostate cancer	4.17e-05	0.000352	CcSEcCtD
Cefazolin—Asthenia—Prednisone—prostate cancer	4.13e-05	0.000349	CcSEcCtD
Cefazolin—Vomiting—Capecitabine—prostate cancer	4.11e-05	0.000347	CcSEcCtD
Cefazolin—Shock—Doxorubicin—prostate cancer	4.1e-05	0.000346	CcSEcCtD
Cefazolin—Thrombocytopenia—Doxorubicin—prostate cancer	4.08e-05	0.000345	CcSEcCtD
Cefazolin—Rash—Capecitabine—prostate cancer	4.08e-05	0.000344	CcSEcCtD
Cefazolin—Pruritus—Prednisone—prostate cancer	4.08e-05	0.000344	CcSEcCtD
Cefazolin—Dermatitis—Capecitabine—prostate cancer	4.08e-05	0.000344	CcSEcCtD
Cefazolin—Headache—Capecitabine—prostate cancer	4.05e-05	0.000342	CcSEcCtD
Cefazolin—Somnolence—Epirubicin—prostate cancer	4.01e-05	0.000338	CcSEcCtD
Cefazolin—Anorexia—Doxorubicin—prostate cancer	3.98e-05	0.000335	CcSEcCtD
Cefazolin—Nausea—Docetaxel—prostate cancer	3.97e-05	0.000335	CcSEcCtD
Cefazolin—Dyspepsia—Epirubicin—prostate cancer	3.97e-05	0.000335	CcSEcCtD
Cefazolin—Diarrhoea—Prednisone—prostate cancer	3.94e-05	0.000333	CcSEcCtD
Cefazolin—Decreased appetite—Epirubicin—prostate cancer	3.92e-05	0.000331	CcSEcCtD
Cefazolin—Hypotension—Doxorubicin—prostate cancer	3.9e-05	0.000329	CcSEcCtD
Cefazolin—Fatigue—Epirubicin—prostate cancer	3.89e-05	0.000328	CcSEcCtD
Cefazolin—Pain—Epirubicin—prostate cancer	3.85e-05	0.000325	CcSEcCtD
Cefazolin—Nausea—Capecitabine—prostate cancer	3.84e-05	0.000324	CcSEcCtD
Cefazolin—Dizziness—Prednisone—prostate cancer	3.81e-05	0.000322	CcSEcCtD
Cefazolin—Feeling abnormal—Epirubicin—prostate cancer	3.71e-05	0.000313	CcSEcCtD
Cefazolin—Somnolence—Doxorubicin—prostate cancer	3.71e-05	0.000313	CcSEcCtD
Cefazolin—Gastrointestinal pain—Epirubicin—prostate cancer	3.69e-05	0.000311	CcSEcCtD
Cefazolin—Dyspepsia—Doxorubicin—prostate cancer	3.67e-05	0.00031	CcSEcCtD
Cefazolin—Vomiting—Prednisone—prostate cancer	3.66e-05	0.000309	CcSEcCtD
Cefazolin—Rash—Prednisone—prostate cancer	3.63e-05	0.000307	CcSEcCtD
Cefazolin—Dermatitis—Prednisone—prostate cancer	3.63e-05	0.000306	CcSEcCtD
Cefazolin—Decreased appetite—Doxorubicin—prostate cancer	3.63e-05	0.000306	CcSEcCtD
Cefazolin—Headache—Prednisone—prostate cancer	3.61e-05	0.000305	CcSEcCtD
Cefazolin—Fatigue—Doxorubicin—prostate cancer	3.6e-05	0.000303	CcSEcCtD
Cefazolin—Urticaria—Epirubicin—prostate cancer	3.58e-05	0.000302	CcSEcCtD
Cefazolin—Pain—Doxorubicin—prostate cancer	3.57e-05	0.000301	CcSEcCtD
Cefazolin—Abdominal pain—Epirubicin—prostate cancer	3.56e-05	0.000301	CcSEcCtD
Cefazolin—Body temperature increased—Epirubicin—prostate cancer	3.56e-05	0.000301	CcSEcCtD
Cefazolin—Feeling abnormal—Doxorubicin—prostate cancer	3.44e-05	0.00029	CcSEcCtD
Cefazolin—Nausea—Prednisone—prostate cancer	3.42e-05	0.000289	CcSEcCtD
Cefazolin—Gastrointestinal pain—Doxorubicin—prostate cancer	3.41e-05	0.000288	CcSEcCtD
Cefazolin—Hypersensitivity—Epirubicin—prostate cancer	3.32e-05	0.00028	CcSEcCtD
Cefazolin—Urticaria—Doxorubicin—prostate cancer	3.31e-05	0.00028	CcSEcCtD
Cefazolin—Abdominal pain—Doxorubicin—prostate cancer	3.3e-05	0.000278	CcSEcCtD
Cefazolin—Body temperature increased—Doxorubicin—prostate cancer	3.3e-05	0.000278	CcSEcCtD
Cefazolin—Asthenia—Epirubicin—prostate cancer	3.23e-05	0.000273	CcSEcCtD
Cefazolin—Pruritus—Epirubicin—prostate cancer	3.19e-05	0.000269	CcSEcCtD
Cefazolin—Diarrhoea—Epirubicin—prostate cancer	3.08e-05	0.00026	CcSEcCtD
Cefazolin—Hypersensitivity—Doxorubicin—prostate cancer	3.07e-05	0.000259	CcSEcCtD
Cefazolin—Asthenia—Doxorubicin—prostate cancer	2.99e-05	0.000253	CcSEcCtD
Cefazolin—Dizziness—Epirubicin—prostate cancer	2.98e-05	0.000252	CcSEcCtD
Cefazolin—Pruritus—Doxorubicin—prostate cancer	2.95e-05	0.000249	CcSEcCtD
Cefazolin—Vomiting—Epirubicin—prostate cancer	2.87e-05	0.000242	CcSEcCtD
Cefazolin—Diarrhoea—Doxorubicin—prostate cancer	2.85e-05	0.000241	CcSEcCtD
Cefazolin—Rash—Epirubicin—prostate cancer	2.84e-05	0.00024	CcSEcCtD
Cefazolin—Dermatitis—Epirubicin—prostate cancer	2.84e-05	0.00024	CcSEcCtD
Cefazolin—Headache—Epirubicin—prostate cancer	2.82e-05	0.000238	CcSEcCtD
Cefazolin—Dizziness—Doxorubicin—prostate cancer	2.76e-05	0.000233	CcSEcCtD
Cefazolin—Nausea—Epirubicin—prostate cancer	2.68e-05	0.000226	CcSEcCtD
Cefazolin—Vomiting—Doxorubicin—prostate cancer	2.65e-05	0.000224	CcSEcCtD
Cefazolin—Rash—Doxorubicin—prostate cancer	2.63e-05	0.000222	CcSEcCtD
Cefazolin—Dermatitis—Doxorubicin—prostate cancer	2.63e-05	0.000222	CcSEcCtD
Cefazolin—Headache—Doxorubicin—prostate cancer	2.61e-05	0.00022	CcSEcCtD
Cefazolin—Nausea—Doxorubicin—prostate cancer	2.48e-05	0.000209	CcSEcCtD
Cefazolin—TPMT—Metabolism—ERCC2—prostate cancer	1.83e-05	0.000285	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—ITPR1—prostate cancer	1.81e-05	0.000283	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	1.81e-05	0.000281	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CLU—prostate cancer	1.77e-05	0.000275	CbGpPWpGaD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	1.75e-05	0.000272	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.73e-05	0.00027	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	1.73e-05	0.00027	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—MTHFR—prostate cancer	1.72e-05	0.000268	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC22A3—prostate cancer	1.72e-05	0.000267	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—SRC—prostate cancer	1.71e-05	0.000266	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—VEGFA—prostate cancer	1.7e-05	0.000264	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PPARA—prostate cancer	1.68e-05	0.000262	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL6—prostate cancer	1.68e-05	0.000262	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	1.67e-05	0.00026	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	1.66e-05	0.000259	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	1.65e-05	0.000257	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GRB7—prostate cancer	1.62e-05	0.000252	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—prostate cancer	1.62e-05	0.000252	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PLAU—prostate cancer	1.61e-05	0.000251	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	1.61e-05	0.000251	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—ITGB3—prostate cancer	1.61e-05	0.00025	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCG5—prostate cancer	1.58e-05	0.000247	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CAV1—prostate cancer	1.58e-05	0.000247	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TST—prostate cancer	1.58e-05	0.000246	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ADI1—prostate cancer	1.58e-05	0.000246	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GRHL1—prostate cancer	1.58e-05	0.000246	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CSAD—prostate cancer	1.58e-05	0.000246	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PSAT1—prostate cancer	1.58e-05	0.000246	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CBR1—prostate cancer	1.58e-05	0.000246	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CAV1—prostate cancer	1.57e-05	0.000245	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.57e-05	0.000245	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—TGFB1—prostate cancer	1.56e-05	0.000242	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	1.54e-05	0.00024	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GNG5—prostate cancer	1.54e-05	0.00024	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	1.53e-05	0.000238	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	1.51e-05	0.000236	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—PPARA—prostate cancer	1.51e-05	0.000235	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TP53—prostate cancer	1.49e-05	0.000233	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—prostate cancer	1.48e-05	0.000231	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CKMT2—prostate cancer	1.47e-05	0.000229	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UGT2B17—prostate cancer	1.47e-05	0.000229	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UGT2B15—prostate cancer	1.47e-05	0.000229	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GRHPR—prostate cancer	1.47e-05	0.000229	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—PPARA—prostate cancer	1.45e-05	0.000226	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CG—prostate cancer	1.44e-05	0.000225	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	1.43e-05	0.000223	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CG—prostate cancer	1.43e-05	0.000223	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—EGF—prostate cancer	1.42e-05	0.000221	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—MED12—prostate cancer	1.41e-05	0.00022	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC22A1—prostate cancer	1.4e-05	0.000218	CbGpPWpGaD
Cefazolin—ALB—Metabolism—RFK—prostate cancer	1.38e-05	0.000215	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTM3—prostate cancer	1.38e-05	0.000215	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NAGLU—prostate cancer	1.38e-05	0.000215	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MBTPS1—prostate cancer	1.38e-05	0.000215	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PGAM2—prostate cancer	1.38e-05	0.000215	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AOX1—prostate cancer	1.38e-05	0.000215	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SULT2B1—prostate cancer	1.38e-05	0.000215	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL6—prostate cancer	1.37e-05	0.000213	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—INS—prostate cancer	1.37e-05	0.000213	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	1.35e-05	0.00021	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CREBBP—prostate cancer	1.34e-05	0.000208	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—GNG5—prostate cancer	1.33e-05	0.000207	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CREBBP—prostate cancer	1.33e-05	0.000207	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IGF1—prostate cancer	1.31e-05	0.000204	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PRKACB—prostate cancer	1.31e-05	0.000204	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AMACR—prostate cancer	1.31e-05	0.000204	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP3A43—prostate cancer	1.31e-05	0.000204	CbGpPWpGaD
Cefazolin—ALB—Metabolism—DEGS1—prostate cancer	1.31e-05	0.000204	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NAT1—prostate cancer	1.31e-05	0.000204	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SRD5A2—prostate cancer	1.31e-05	0.000204	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	1.3e-05	0.000202	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.29e-05	0.0002	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	1.28e-05	0.000199	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—THBS1—prostate cancer	1.28e-05	0.000199	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CD—prostate cancer	1.27e-05	0.000198	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	1.26e-05	0.000196	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CD—prostate cancer	1.26e-05	0.000196	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CG—prostate cancer	1.26e-05	0.000196	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HSD17B1—prostate cancer	1.25e-05	0.000194	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.25e-05	0.000194	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SERPINE1—prostate cancer	1.25e-05	0.000194	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—EGF—prostate cancer	1.24e-05	0.000194	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PRKCZ—prostate cancer	1.24e-05	0.000193	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.2e-05	0.000187	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.2e-05	0.000187	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NOS3—prostate cancer	1.2e-05	0.000187	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.19e-05	0.000186	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NOS3—prostate cancer	1.19e-05	0.000185	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.18e-05	0.000184	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—JAK2—prostate cancer	1.16e-05	0.00018	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IGF1—prostate cancer	1.15e-05	0.000179	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.15e-05	0.000179	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.13e-05	0.000177	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.13e-05	0.000175	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HPGD—prostate cancer	1.11e-05	0.000173	CbGpPWpGaD
Cefazolin—ALB—Metabolism—B4GALT4—prostate cancer	1.11e-05	0.000173	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CD—prostate cancer	1.11e-05	0.000172	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CB—prostate cancer	1.11e-05	0.000172	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CB—prostate cancer	1.1e-05	0.000171	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTGS2—prostate cancer	1.1e-05	0.000171	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SERPINE1—prostate cancer	1.09e-05	0.00017	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL6—prostate cancer	1.09e-05	0.000169	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.07e-05	0.000167	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—AKT1—prostate cancer	1.06e-05	0.000165	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PRKCQ—prostate cancer	1.05e-05	0.000164	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TNFRSF21—prostate cancer	1.05e-05	0.000163	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PLAUR—prostate cancer	1.04e-05	0.000162	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.02e-05	0.000159	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP7B1—prostate cancer	1.02e-05	0.000158	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTAP—prostate cancer	1.02e-05	0.000158	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—JAK2—prostate cancer	1.01e-05	0.000158	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IL2—prostate cancer	1.01e-05	0.000157	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	1e-05	0.000156	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	9.94e-06	0.000155	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SULT1E1—prostate cancer	9.91e-06	0.000154	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SRD5A1—prostate cancer	9.91e-06	0.000154	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VAV3—prostate cancer	9.64e-06	0.00015	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CB—prostate cancer	9.64e-06	0.00015	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	9.63e-06	0.00015	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTEN—prostate cancer	9.55e-06	0.000149	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	9.48e-06	0.000148	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HSD17B3—prostate cancer	9.46e-06	0.000147	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ACSL4—prostate cancer	9.46e-06	0.000147	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ITPR1—prostate cancer	9.35e-06	0.000146	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	9.35e-06	0.000146	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—EP300—prostate cancer	9.11e-06	0.000142	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PHGDH—prostate cancer	9.07e-06	0.000141	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ARG2—prostate cancer	9.07e-06	0.000141	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UMPS—prostate cancer	9.07e-06	0.000141	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—EP300—prostate cancer	9.05e-06	0.000141	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	9.02e-06	0.000141	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—NCOA1—prostate cancer	9.02e-06	0.000141	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LDHB—prostate cancer	8.89e-06	0.000139	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IL2—prostate cancer	8.85e-06	0.000138	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SRC—prostate cancer	8.8e-06	0.000137	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP3A5—prostate cancer	8.73e-06	0.000136	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—RXRA—prostate cancer	8.58e-06	0.000134	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—VEGFA—prostate cancer	8.57e-06	0.000133	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UCP3—prostate cancer	8.43e-06	0.000131	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TCN2—prostate cancer	8.43e-06	0.000131	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA3—prostate cancer	8.43e-06	0.000131	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PDHA1—prostate cancer	8.43e-06	0.000131	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ITGB3—prostate cancer	8.28e-06	0.000129	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC22A3—prostate cancer	8.04e-06	0.000125	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HSD3B1—prostate cancer	8.04e-06	0.000125	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TGFB1—prostate cancer	7.86e-06	0.000123	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—LPL—prostate cancer	7.8e-06	0.000122	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SRC—prostate cancer	7.72e-06	0.00012	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TBXAS1—prostate cancer	7.71e-06	0.00012	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA4—prostate cancer	7.71e-06	0.00012	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	7.53e-06	0.000117	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	7.52e-06	0.000117	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA2—prostate cancer	7.51e-06	0.000117	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ABCG5—prostate cancer	7.42e-06	0.000116	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SULT1A1—prostate cancer	7.42e-06	0.000116	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PLAU—prostate cancer	7.29e-06	0.000114	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—KRAS—prostate cancer	7.28e-06	0.000113	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA1—prostate cancer	7.25e-06	0.000113	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NAT2—prostate cancer	7.17e-06	0.000112	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HSD3B2—prostate cancer	7.17e-06	0.000112	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTO1—prostate cancer	7.17e-06	0.000112	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CAV1—prostate cancer	7.12e-06	0.000111	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	6.9e-06	0.000108	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.89e-06	0.000107	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PLCB2—prostate cancer	6.87e-06	0.000107	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LRP2—prostate cancer	6.87e-06	0.000107	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2C18—prostate cancer	6.87e-06	0.000107	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CA—prostate cancer	6.74e-06	0.000105	CbGpPWpGaD
Cefazolin—ALB—Metabolism—P4HB—prostate cancer	6.74e-06	0.000105	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CA—prostate cancer	6.69e-06	0.000104	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC22A1—prostate cancer	6.55e-06	0.000102	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	6.55e-06	0.000102	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CG—prostate cancer	6.48e-06	0.000101	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.48e-06	0.000101	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TP53—prostate cancer	6.47e-06	0.000101	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—EGF—prostate cancer	6.41e-06	9.98e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SULT2A1—prostate cancer	6.39e-06	9.95e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MED12—prostate cancer	6.28e-06	9.79e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GNG5—prostate cancer	6.23e-06	9.71e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CREBBP—prostate cancer	6.01e-06	9.36e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOA3—prostate cancer	6.01e-06	9.36e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IGF1—prostate cancer	5.94e-06	9.25e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.9e-06	9.19e-05	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	5.87e-06	9.15e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HPGDS—prostate cancer	5.73e-06	8.93e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CD—prostate cancer	5.7e-06	8.88e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2C19—prostate cancer	5.69e-06	8.87e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SERPINE1—prostate cancer	5.64e-06	8.78e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ACHE—prostate cancer	5.56e-06	8.66e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTT1—prostate cancer	5.56e-06	8.66e-05	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—AKT1—prostate cancer	5.5e-06	8.58e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2A6—prostate cancer	5.49e-06	8.56e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.47e-06	8.53e-05	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT1—prostate cancer	5.47e-06	8.52e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NOS3—prostate cancer	5.38e-06	8.38e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKR1C3—prostate cancer	5.34e-06	8.33e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PRKACB—prostate cancer	5.32e-06	8.28e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP17A1—prostate cancer	5.26e-06	8.2e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—JAK2—prostate cancer	5.23e-06	8.15e-05	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.2e-06	8.11e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.19e-06	8.08e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOA2—prostate cancer	5.01e-06	7.81e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CB—prostate cancer	4.97e-06	7.74e-05	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	4.8e-06	7.48e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC5A5—prostate cancer	4.78e-06	7.45e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2E1—prostate cancer	4.67e-06	7.28e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NQO1—prostate cancer	4.62e-06	7.2e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IL2—prostate cancer	4.56e-06	7.11e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TH—prostate cancer	4.55e-06	7.09e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.52e-06	7.05e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP3A4—prostate cancer	4.5e-06	7.02e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.48e-06	6.98e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP1B1—prostate cancer	4.43e-06	6.9e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GGT1—prostate cancer	4.29e-06	6.68e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOA1—prostate cancer	4.22e-06	6.58e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP19A1—prostate cancer	4.16e-06	6.49e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—EP300—prostate cancer	4.09e-06	6.38e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—RXRA—prostate cancer	4.02e-06	6.26e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SRC—prostate cancer	3.98e-06	6.2e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.91e-06	6.09e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VEGFA—prostate cancer	3.88e-06	6.04e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—COMT—prostate cancer	3.87e-06	6.03e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTP1—prostate cancer	3.85e-06	6e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ITPR1—prostate cancer	3.79e-06	5.91e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.73e-06	5.81e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TYMS—prostate cancer	3.58e-06	5.58e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TGFB1—prostate cancer	3.56e-06	5.54e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTM1—prostate cancer	3.54e-06	5.51e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LPL—prostate cancer	3.47e-06	5.41e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP1A1—prostate cancer	3.36e-06	5.23e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ERCC2—prostate cancer	3.33e-06	5.18e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—KRAS—prostate cancer	3.3e-06	5.14e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTHFR—prostate cancer	3.13e-06	4.87e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARA—prostate cancer	3.07e-06	4.78e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CA—prostate cancer	3.03e-06	4.72e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TP53—prostate cancer	2.93e-06	4.56e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CAV1—prostate cancer	2.89e-06	4.5e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.76e-06	4.29e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CG—prostate cancer	2.63e-06	4.09e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—INS—prostate cancer	2.49e-06	3.88e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT1—prostate cancer	2.47e-06	3.85e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CREBBP—prostate cancer	2.44e-06	3.8e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CD—prostate cancer	2.31e-06	3.6e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NOS3—prostate cancer	2.18e-06	3.4e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CB—prostate cancer	2.01e-06	3.14e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTGS2—prostate cancer	2e-06	3.11e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTEN—prostate cancer	1.74e-06	2.71e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—EP300—prostate cancer	1.66e-06	2.59e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CA—prostate cancer	1.23e-06	1.91e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKT1—prostate cancer	1e-06	1.56e-05	CbGpPWpGaD
